GAP43 and major depressive disorder: Additionally, some novel potential therapeutic targets for MDD have also been reported, such as TGF-β1389 and growth-associated protein 43 (GAP-43).390 Multiple studies have shown that antidepressants may cause changes in TGF-β1 expression.